Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women

Wyeth

Status: Completed

Conditions: Postmenopause

Treatments: Drug: Conjugated Estrogen Cream (Premarin®)

Study type: Observational

Funder types: Industry

Identifiers

NCT00484107

0713V-101833

Details and patient eligibility

About

This post-marketing study will provide local safety and tolerance data on the use of Premarin® vaginal cream.

Sex: Female

Ages: 40 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients in whom Premarin vaginal cream is indicated.
• In the opinion of the investigator, sufficient intelligence and motivation for the patient to continue throughout the study.
• Provide signed informed consent.

Exclusion criteria

• Patients not willing to give informed consent.